Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Expert Review of Hematology|July 26, 2023
Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectivesPeter Valent, Irina Sadovnik, Barbara Peter, et al.
Blood|August 30, 2007
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patientsDetlef Haase, Ulrich Germing, Julie Schanz, et al.
Haematologica|August 5, 2018
Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment conceptsPeter Valent, Guntram Büsche, Igor Theurl, et al.
Leukemia Research|January 30, 2007
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conferencePeter Valent, Hans-Peter Horny, John M Bennett, et al.
Wiener Klinische Wochenschrift|July 15, 2018
Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectivesPeter Valent, Emir Hadzijusufovic, Thomas Grunt, et al.
Blood|August 11, 2020
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosisGeorg Greiner, Bettina Sprinzl, Aleksandra Górska, et al.
Journal of Hematology & Oncology|April 17, 2016
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classificationsLisa Pleyer, Sonja Burgstaller, Reinhard Stauder, et al.
Cancers|May 28, 2022
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-GroupMichael Leisch, Michael Pfeilstöcker, Reinhard Stauder, et al.
Genes, Chromosomes & Cancer|September 25, 2018
Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significanceJulie Schanz, Francesc Solé, Mar Mallo, et al.
Annals of Hematology|January 17, 2009
Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group for Studying Prognostic Factors in Myelodysplastic SyndromesPeter Valent, Wolf-Karsten Hofmann, Guntram Büsche, et al.
Pageof 6